The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Coronary Drug-Eluting Stent Market Research Report 2025

Global Coronary Drug-Eluting Stent Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1914082

No of Pages : 91

Ask Your Query
Synopsis
The global Coronary Drug-Eluting Stent market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Coronary Drug-Eluting Stent is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Coronary Drug-Eluting Stent is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Coronary Drug-Eluting Stent include Medtronic, Boston Scientific, Abbott, B.Braun, Biosensors International, MicroPort, Lepu Medical, Terumo and Blue Sail Medical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Coronary Drug-Eluting Stent, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Coronary Drug-Eluting Stent.
Report Scope
The Coronary Drug-Eluting Stent market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Coronary Drug-Eluting Stent market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Coronary Drug-Eluting Stent manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Medtronic
Boston Scientific
Abbott
B.Braun
Biosensors International
MicroPort
Lepu Medical
Terumo
Blue Sail Medical
SINOMED
Liaoning Yinyi Biological
Segment by Type
Polymer Stent
Polymer-Free Stent
Others
Segment by Application
Hospital
Clinic
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Coronary Drug-Eluting Stent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Coronary Drug-Eluting Stent in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Coronary Drug-Eluting Stent Market Overview
1.1 Product Overview and Scope of Coronary Drug-Eluting Stent
1.2 Coronary Drug-Eluting Stent Segment by Type
1.2.1 Global Coronary Drug-Eluting Stent Market Value Comparison by Type (2024-2030)
1.2.2 Polymer Stent
1.2.3 Polymer-Free Stent
1.2.4 Others
1.3 Coronary Drug-Eluting Stent Segment by Application
1.3.1 Global Coronary Drug-Eluting Stent Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Coronary Drug-Eluting Stent Market Size Estimates and Forecasts
1.4.1 Global Coronary Drug-Eluting Stent Revenue 2019-2030
1.4.2 Global Coronary Drug-Eluting Stent Sales 2019-2030
1.4.3 Global Coronary Drug-Eluting Stent Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Coronary Drug-Eluting Stent Market Competition by Manufacturers
2.1 Global Coronary Drug-Eluting Stent Sales Market Share by Manufacturers (2019-2024)
2.2 Global Coronary Drug-Eluting Stent Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Coronary Drug-Eluting Stent Average Price by Manufacturers (2019-2024)
2.4 Global Coronary Drug-Eluting Stent Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Coronary Drug-Eluting Stent, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Coronary Drug-Eluting Stent, Product Type & Application
2.7 Coronary Drug-Eluting Stent Market Competitive Situation and Trends
2.7.1 Coronary Drug-Eluting Stent Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Coronary Drug-Eluting Stent Players Market Share by Revenue
2.7.3 Global Coronary Drug-Eluting Stent Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Coronary Drug-Eluting Stent Retrospective Market Scenario by Region
3.1 Global Coronary Drug-Eluting Stent Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Coronary Drug-Eluting Stent Global Coronary Drug-Eluting Stent Sales by Region: 2019-2030
3.2.1 Global Coronary Drug-Eluting Stent Sales by Region: 2019-2024
3.2.2 Global Coronary Drug-Eluting Stent Sales by Region: 2025-2030
3.3 Global Coronary Drug-Eluting Stent Global Coronary Drug-Eluting Stent Revenue by Region: 2019-2030
3.3.1 Global Coronary Drug-Eluting Stent Revenue by Region: 2019-2024
3.3.2 Global Coronary Drug-Eluting Stent Revenue by Region: 2025-2030
3.4 North America Coronary Drug-Eluting Stent Market Facts & Figures by Country
3.4.1 North America Coronary Drug-Eluting Stent Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Coronary Drug-Eluting Stent Sales by Country (2019-2030)
3.4.3 North America Coronary Drug-Eluting Stent Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Coronary Drug-Eluting Stent Market Facts & Figures by Country
3.5.1 Europe Coronary Drug-Eluting Stent Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Coronary Drug-Eluting Stent Sales by Country (2019-2030)
3.5.3 Europe Coronary Drug-Eluting Stent Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Netherlands
3.6 Asia Pacific Coronary Drug-Eluting Stent Market Facts & Figures by Country
3.6.1 Asia Pacific Coronary Drug-Eluting Stent Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Coronary Drug-Eluting Stent Sales by Country (2019-2030)
3.6.3 Asia Pacific Coronary Drug-Eluting Stent Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Southeast Asia
3.6.9 China Taiwan
3.6.10 Australia
3.7 Latin America Coronary Drug-Eluting Stent Market Facts & Figures by Country
3.7.1 Latin America Coronary Drug-Eluting Stent Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Coronary Drug-Eluting Stent Sales by Country (2019-2030)
3.7.3 Latin America Coronary Drug-Eluting Stent Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Coronary Drug-Eluting Stent Market Facts & Figures by Country
3.8.1 Middle East and Africa Coronary Drug-Eluting Stent Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Coronary Drug-Eluting Stent Sales by Country (2019-2030)
3.8.3 Middle East and Africa Coronary Drug-Eluting Stent Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Coronary Drug-Eluting Stent Sales by Type (2019-2030)
4.1.1 Global Coronary Drug-Eluting Stent Sales by Type (2019-2024)
4.1.2 Global Coronary Drug-Eluting Stent Sales by Type (2025-2030)
4.1.3 Global Coronary Drug-Eluting Stent Sales Market Share by Type (2019-2030)
4.2 Global Coronary Drug-Eluting Stent Revenue by Type (2019-2030)
4.2.1 Global Coronary Drug-Eluting Stent Revenue by Type (2019-2024)
4.2.2 Global Coronary Drug-Eluting Stent Revenue by Type (2025-2030)
4.2.3 Global Coronary Drug-Eluting Stent Revenue Market Share by Type (2019-2030)
4.3 Global Coronary Drug-Eluting Stent Price by Type (2019-2030)
5 Segment by Application
5.1 Global Coronary Drug-Eluting Stent Sales by Application (2019-2030)
5.1.1 Global Coronary Drug-Eluting Stent Sales by Application (2019-2024)
5.1.2 Global Coronary Drug-Eluting Stent Sales by Application (2025-2030)
5.1.3 Global Coronary Drug-Eluting Stent Sales Market Share by Application (2019-2030)
5.2 Global Coronary Drug-Eluting Stent Revenue by Application (2019-2030)
5.2.1 Global Coronary Drug-Eluting Stent Revenue by Application (2019-2024)
5.2.2 Global Coronary Drug-Eluting Stent Revenue by Application (2025-2030)
5.2.3 Global Coronary Drug-Eluting Stent Revenue Market Share by Application (2019-2030)
5.3 Global Coronary Drug-Eluting Stent Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Medtronic
6.1.1 Medtronic Corporation Information
6.1.2 Medtronic Description and Business Overview
6.1.3 Medtronic Coronary Drug-Eluting Stent Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Medtronic Coronary Drug-Eluting Stent Product Portfolio
6.1.5 Medtronic Recent Developments/Updates
6.2 Boston Scientific
6.2.1 Boston Scientific Corporation Information
6.2.2 Boston Scientific Description and Business Overview
6.2.3 Boston Scientific Coronary Drug-Eluting Stent Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Boston Scientific Coronary Drug-Eluting Stent Product Portfolio
6.2.5 Boston Scientific Recent Developments/Updates
6.3 Abbott
6.3.1 Abbott Corporation Information
6.3.2 Abbott Description and Business Overview
6.3.3 Abbott Coronary Drug-Eluting Stent Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Abbott Coronary Drug-Eluting Stent Product Portfolio
6.3.5 Abbott Recent Developments/Updates
6.4 B.Braun
6.4.1 B.Braun Corporation Information
6.4.2 B.Braun Description and Business Overview
6.4.3 B.Braun Coronary Drug-Eluting Stent Sales, Revenue and Gross Margin (2019-2024)
6.4.4 B.Braun Coronary Drug-Eluting Stent Product Portfolio
6.4.5 B.Braun Recent Developments/Updates
6.5 Biosensors International
6.5.1 Biosensors International Corporation Information
6.5.2 Biosensors International Description and Business Overview
6.5.3 Biosensors International Coronary Drug-Eluting Stent Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Biosensors International Coronary Drug-Eluting Stent Product Portfolio
6.5.5 Biosensors International Recent Developments/Updates
6.6 MicroPort
6.6.1 MicroPort Corporation Information
6.6.2 MicroPort Description and Business Overview
6.6.3 MicroPort Coronary Drug-Eluting Stent Sales, Revenue and Gross Margin (2019-2024)
6.6.4 MicroPort Coronary Drug-Eluting Stent Product Portfolio
6.6.5 MicroPort Recent Developments/Updates
6.7 Lepu Medical
6.6.1 Lepu Medical Corporation Information
6.6.2 Lepu Medical Description and Business Overview
6.6.3 Lepu Medical Coronary Drug-Eluting Stent Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Lepu Medical Coronary Drug-Eluting Stent Product Portfolio
6.7.5 Lepu Medical Recent Developments/Updates
6.8 Terumo
6.8.1 Terumo Corporation Information
6.8.2 Terumo Description and Business Overview
6.8.3 Terumo Coronary Drug-Eluting Stent Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Terumo Coronary Drug-Eluting Stent Product Portfolio
6.8.5 Terumo Recent Developments/Updates
6.9 Blue Sail Medical
6.9.1 Blue Sail Medical Corporation Information
6.9.2 Blue Sail Medical Description and Business Overview
6.9.3 Blue Sail Medical Coronary Drug-Eluting Stent Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Blue Sail Medical Coronary Drug-Eluting Stent Product Portfolio
6.9.5 Blue Sail Medical Recent Developments/Updates
6.10 SINOMED
6.10.1 SINOMED Corporation Information
6.10.2 SINOMED Description and Business Overview
6.10.3 SINOMED Coronary Drug-Eluting Stent Sales, Revenue and Gross Margin (2019-2024)
6.10.4 SINOMED Coronary Drug-Eluting Stent Product Portfolio
6.10.5 SINOMED Recent Developments/Updates
6.11 Liaoning Yinyi Biological
6.11.1 Liaoning Yinyi Biological Corporation Information
6.11.2 Liaoning Yinyi Biological Coronary Drug-Eluting Stent Description and Business Overview
6.11.3 Liaoning Yinyi Biological Coronary Drug-Eluting Stent Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Liaoning Yinyi Biological Coronary Drug-Eluting Stent Product Portfolio
6.11.5 Liaoning Yinyi Biological Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Coronary Drug-Eluting Stent Industry Chain Analysis
7.2 Coronary Drug-Eluting Stent Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Coronary Drug-Eluting Stent Production Mode & Process
7.4 Coronary Drug-Eluting Stent Sales and Marketing
7.4.1 Coronary Drug-Eluting Stent Sales Channels
7.4.2 Coronary Drug-Eluting Stent Distributors
7.5 Coronary Drug-Eluting Stent Customers
8 Coronary Drug-Eluting Stent Market Dynamics
8.1 Coronary Drug-Eluting Stent Industry Trends
8.2 Coronary Drug-Eluting Stent Market Drivers
8.3 Coronary Drug-Eluting Stent Market Challenges
8.4 Coronary Drug-Eluting Stent Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
List of Tables
Table 1. Global Coronary Drug-Eluting Stent Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Coronary Drug-Eluting Stent Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Coronary Drug-Eluting Stent Market Competitive Situation by Manufacturers in 2023
Table 4. Global Coronary Drug-Eluting Stent Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Coronary Drug-Eluting Stent Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Coronary Drug-Eluting Stent Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Coronary Drug-Eluting Stent Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Coronary Drug-Eluting Stent Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Coronary Drug-Eluting Stent, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Coronary Drug-Eluting Stent, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Coronary Drug-Eluting Stent, Product Type & Application
Table 12. Global Key Manufacturers of Coronary Drug-Eluting Stent, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Coronary Drug-Eluting Stent by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Coronary Drug-Eluting Stent as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Coronary Drug-Eluting Stent Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Coronary Drug-Eluting Stent Sales by Region (2019-2024) & (K Units)
Table 18. Global Coronary Drug-Eluting Stent Sales Market Share by Region (2019-2024)
Table 19. Global Coronary Drug-Eluting Stent Sales by Region (2025-2030) & (K Units)
Table 20. Global Coronary Drug-Eluting Stent Sales Market Share by Region (2025-2030)
Table 21. Global Coronary Drug-Eluting Stent Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Coronary Drug-Eluting Stent Revenue Market Share by Region (2019-2024)
Table 23. Global Coronary Drug-Eluting Stent Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Coronary Drug-Eluting Stent Revenue Market Share by Region (2025-2030)
Table 25. North America Coronary Drug-Eluting Stent Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Coronary Drug-Eluting Stent Sales by Country (2019-2024) & (K Units)
Table 27. North America Coronary Drug-Eluting Stent Sales by Country (2025-2030) & (K Units)
Table 28. North America Coronary Drug-Eluting Stent Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Coronary Drug-Eluting Stent Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Coronary Drug-Eluting Stent Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Coronary Drug-Eluting Stent Sales by Country (2019-2024) & (K Units)
Table 32. Europe Coronary Drug-Eluting Stent Sales by Country (2025-2030) & (K Units)
Table 33. Europe Coronary Drug-Eluting Stent Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Coronary Drug-Eluting Stent Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Coronary Drug-Eluting Stent Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Coronary Drug-Eluting Stent Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Coronary Drug-Eluting Stent Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Coronary Drug-Eluting Stent Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Coronary Drug-Eluting Stent Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Coronary Drug-Eluting Stent Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Coronary Drug-Eluting Stent Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Coronary Drug-Eluting Stent Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Coronary Drug-Eluting Stent Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Coronary Drug-Eluting Stent Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Coronary Drug-Eluting Stent Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Coronary Drug-Eluting Stent Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Coronary Drug-Eluting Stent Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Coronary Drug-Eluting Stent Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Coronary Drug-Eluting Stent Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Coronary Drug-Eluting Stent Sales (K Units) by Type (2019-2024)
Table 51. Global Coronary Drug-Eluting Stent Sales (K Units) by Type (2025-2030)
Table 52. Global Coronary Drug-Eluting Stent Sales Market Share by Type (2019-2024)
Table 53. Global Coronary Drug-Eluting Stent Sales Market Share by Type (2025-2030)
Table 54. Global Coronary Drug-Eluting Stent Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Coronary Drug-Eluting Stent Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Coronary Drug-Eluting Stent Revenue Market Share by Type (2019-2024)
Table 57. Global Coronary Drug-Eluting Stent Revenue Market Share by Type (2025-2030)
Table 58. Global Coronary Drug-Eluting Stent Price (US$/Unit) by Type (2019-2024)
Table 59. Global Coronary Drug-Eluting Stent Price (US$/Unit) by Type (2025-2030)
Table 60. Global Coronary Drug-Eluting Stent Sales (K Units) by Application (2019-2024)
Table 61. Global Coronary Drug-Eluting Stent Sales (K Units) by Application (2025-2030)
Table 62. Global Coronary Drug-Eluting Stent Sales Market Share by Application (2019-2024)
Table 63. Global Coronary Drug-Eluting Stent Sales Market Share by Application (2025-2030)
Table 64. Global Coronary Drug-Eluting Stent Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Coronary Drug-Eluting Stent Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Coronary Drug-Eluting Stent Revenue Market Share by Application (2019-2024)
Table 67. Global Coronary Drug-Eluting Stent Revenue Market Share by Application (2025-2030)
Table 68. Global Coronary Drug-Eluting Stent Price (US$/Unit) by Application (2019-2024)
Table 69. Global Coronary Drug-Eluting Stent Price (US$/Unit) by Application (2025-2030)
Table 70. Medtronic Corporation Information
Table 71. Medtronic Description and Business Overview
Table 72. Medtronic Coronary Drug-Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Medtronic Coronary Drug-Eluting Stent Product
Table 74. Medtronic Recent Developments/Updates
Table 75. Boston Scientific Corporation Information
Table 76. Boston Scientific Description and Business Overview
Table 77. Boston Scientific Coronary Drug-Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Boston Scientific Coronary Drug-Eluting Stent Product
Table 79. Boston Scientific Recent Developments/Updates
Table 80. Abbott Corporation Information
Table 81. Abbott Description and Business Overview
Table 82. Abbott Coronary Drug-Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Abbott Coronary Drug-Eluting Stent Product
Table 84. Abbott Recent Developments/Updates
Table 85. B.Braun Corporation Information
Table 86. B.Braun Description and Business Overview
Table 87. B.Braun Coronary Drug-Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. B.Braun Coronary Drug-Eluting Stent Product
Table 89. B.Braun Recent Developments/Updates
Table 90. Biosensors International Corporation Information
Table 91. Biosensors International Description and Business Overview
Table 92. Biosensors International Coronary Drug-Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Biosensors International Coronary Drug-Eluting Stent Product
Table 94. Biosensors International Recent Developments/Updates
Table 95. MicroPort Corporation Information
Table 96. MicroPort Description and Business Overview
Table 97. MicroPort Coronary Drug-Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. MicroPort Coronary Drug-Eluting Stent Product
Table 99. MicroPort Recent Developments/Updates
Table 100. Lepu Medical Corporation Information
Table 101. Lepu Medical Description and Business Overview
Table 102. Lepu Medical Coronary Drug-Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Lepu Medical Coronary Drug-Eluting Stent Product
Table 104. Lepu Medical Recent Developments/Updates
Table 105. Terumo Corporation Information
Table 106. Terumo Description and Business Overview
Table 107. Terumo Coronary Drug-Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Terumo Coronary Drug-Eluting Stent Product
Table 109. Terumo Recent Developments/Updates
Table 110. Blue Sail Medical Corporation Information
Table 111. Blue Sail Medical Description and Business Overview
Table 112. Blue Sail Medical Coronary Drug-Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Blue Sail Medical Coronary Drug-Eluting Stent Product
Table 114. Blue Sail Medical Recent Developments/Updates
Table 115. SINOMED Corporation Information
Table 116. SINOMED Description and Business Overview
Table 117. SINOMED Coronary Drug-Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. SINOMED Coronary Drug-Eluting Stent Product
Table 119. SINOMED Recent Developments/Updates
Table 120. Liaoning Yinyi Biological Corporation Information
Table 121. Liaoning Yinyi Biological Description and Business Overview
Table 122. Liaoning Yinyi Biological Coronary Drug-Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Liaoning Yinyi Biological Coronary Drug-Eluting Stent Product
Table 124. Liaoning Yinyi Biological Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Coronary Drug-Eluting Stent Distributors List
Table 128. Coronary Drug-Eluting Stent Customers List
Table 129. Coronary Drug-Eluting Stent Market Trends
Table 130. Coronary Drug-Eluting Stent Market Drivers
Table 131. Coronary Drug-Eluting Stent Market Challenges
Table 132. Coronary Drug-Eluting Stent Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Coronary Drug-Eluting Stent
Figure 2. Global Coronary Drug-Eluting Stent Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Coronary Drug-Eluting Stent Market Share by Type in 2023 & 2030
Figure 4. Polymer Stent Product Picture
Figure 5. Polymer-Free Stent Product Picture
Figure 6. Others Product Picture
Figure 7. Global Coronary Drug-Eluting Stent Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Coronary Drug-Eluting Stent Market Share by Application in 2023 & 2030
Figure 9. Hospital
Figure 10. Clinic
Figure 11. Global Coronary Drug-Eluting Stent Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Coronary Drug-Eluting Stent Market Size (2019-2030) & (US$ Million)
Figure 13. Global Coronary Drug-Eluting Stent Sales (2019-2030) & (K Units)
Figure 14. Global Coronary Drug-Eluting Stent Average Price (US$/Unit) & (2019-2030)
Figure 15. Coronary Drug-Eluting Stent Report Years Considered
Figure 16. Coronary Drug-Eluting Stent Sales Share by Manufacturers in 2023
Figure 17. Global Coronary Drug-Eluting Stent Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Coronary Drug-Eluting Stent Players: Market Share by Revenue in 2023
Figure 19. Coronary Drug-Eluting Stent Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Coronary Drug-Eluting Stent Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Coronary Drug-Eluting Stent Sales Market Share by Country (2019-2030)
Figure 22. North America Coronary Drug-Eluting Stent Revenue Market Share by Country (2019-2030)
Figure 23. United States Coronary Drug-Eluting Stent Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Coronary Drug-Eluting Stent Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Coronary Drug-Eluting Stent Sales Market Share by Country (2019-2030)
Figure 26. Europe Coronary Drug-Eluting Stent Revenue Market Share by Country (2019-2030)
Figure 27. Germany Coronary Drug-Eluting Stent Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Coronary Drug-Eluting Stent Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Coronary Drug-Eluting Stent Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Coronary Drug-Eluting Stent Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Netherlands Coronary Drug-Eluting Stent Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Coronary Drug-Eluting Stent Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Coronary Drug-Eluting Stent Revenue Market Share by Region (2019-2030)
Figure 34. China Coronary Drug-Eluting Stent Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Coronary Drug-Eluting Stent Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Coronary Drug-Eluting Stent Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Coronary Drug-Eluting Stent Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Southeast Asia Coronary Drug-Eluting Stent Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. China Taiwan Coronary Drug-Eluting Stent Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Australia Coronary Drug-Eluting Stent Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Latin America Coronary Drug-Eluting Stent Sales Market Share by Country (2019-2030)
Figure 42. Latin America Coronary Drug-Eluting Stent Revenue Market Share by Country (2019-2030)
Figure 43. Mexico Coronary Drug-Eluting Stent Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Brazil Coronary Drug-Eluting Stent Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Argentina Coronary Drug-Eluting Stent Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Colombia Coronary Drug-Eluting Stent Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Coronary Drug-Eluting Stent Sales Market Share by Country (2019-2030)
Figure 48. Middle East & Africa Coronary Drug-Eluting Stent Revenue Market Share by Country (2019-2030)
Figure 49. Turkey Coronary Drug-Eluting Stent Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Saudi Arabia Coronary Drug-Eluting Stent Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. UAE Coronary Drug-Eluting Stent Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Global Sales Market Share of Coronary Drug-Eluting Stent by Type (2019-2030)
Figure 53. Global Revenue Market Share of Coronary Drug-Eluting Stent by Type (2019-2030)
Figure 54. Global Coronary Drug-Eluting Stent Price (US$/Unit) by Type (2019-2030)
Figure 55. Global Sales Market Share of Coronary Drug-Eluting Stent by Application (2019-2030)
Figure 56. Global Revenue Market Share of Coronary Drug-Eluting Stent by Application (2019-2030)
Figure 57. Global Coronary Drug-Eluting Stent Price (US$/Unit) by Application (2019-2030)
Figure 58. Coronary Drug-Eluting Stent Value Chain
Figure 59. Coronary Drug-Eluting Stent Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock